Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500114714Phase 4Not yet recruiting
Phase 4, randomised trial of bupivacaine in lumbar spinal stenosis (LSS) and lumbar spondylolisthesis (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoints: Physical Activity VAS Score at 24 hours postoperatively and Cumulative opioid consumption 72h postoperatively. Planned start Dec 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500114714.